During 2017, the Commission analysed the data from the first year of monitoring of the substances in the first watch list. On the basis of that analysis, the Commission concluded that sufficient high-quality monitoring data are available for the substances tri-allate, oxadiazon, 2,6-ditert-butyl-4-methylphenol and diclofenac, and that, therefore, those substances should be removed from the watch list.
Recital 7, Commission Implementing Decision (EU) 2018/840 of 5 June 2018 establishing a watch list…
In forcesince 5 Jun 2018